Screening And Characterisation Of Mammalian Epigenetic Modifiers
Funder
National Health and Medical Research Council
Funding Amount
$470,143.00
Summary
All the information to form an adult is contained in the DNA of the fertilized egg. Development is achieved by turning genes on and off, controlled by proteins called epigenetic modifiers. Sometimes this fails, leading to disease. Despite their vital role, we have data on just 20% of the potential epigenetic modifiers in humans. I will use novel screen-based technology to find hundreds more, to enable us and others to characterise the role of epigenetics in normal development and disease.
Dysferlin Coordinates Membrane Repair For Skeletal And Cardiac Injury
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
Muscles are damaged all of the time, as we stretch and contract them, but we don't fully understand how they repair themselves. We are studying the molecular steps taken by a muscle cell to repair membrane damage. Our research will provide valuable insights into how to treat muscular dystrophy and other conditions characterised by membrane damage to cells, such as heart attack and stroke.
Control Of TGF-beta Superfamily Signalling In Human Disease
Funder
National Health and Medical Research Council
Funding Amount
$443,946.00
Summary
Members of the transforming growth factor ? (TGF-?) family of proteins play crucial roles in adult tissue homeostasis. In recent years a new paradigm has emerged suggesting that inhibition of TGF-? signalling could be an effective strategy for restoring homeostasis in disease-affected tissues. Dr Harrison’s overall research strategy is based on this concept, and is particularly focussed on developing specific antagonists of individual TGF-? proteins.